# Anika Therapeutics, Inc.: Form 8-K, filed Aug 8, 2023

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 8-K
- Filed: 2023-08-08
- Accepted by EDGAR: Aug 8, 2023, 16:11 ET
- Period: 2023-08-08
- Accession: 0001171843-23-005107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184323005107/f8k_080823.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184323005107/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184323005107/f8k_080823.htm

Filed Aug 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-005107. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.